Literature DB >> 15729567

The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.

Morgan E Wallace1, Mark J Smyth.   

Abstract

Natural killer (NK) cells are the primary effector cells of the innate immune system and have a well-established role in tumor rejection in a variety of spontaneous and induced cancer models. NK cell function is regulated by a complex balance of inhibitory and activating signals that allow them to selectively target and kill cells that display an abnormal pattern of cell surface molecules, while leaving normal healthy cells unharmed. In this review we discuss NK cell function, the role of NK cells in cancer therapies, the emerging concept of bi-directional cross-talk between NK cells and dendritic cells, and the implications of these interactions for tumor immunotherapy.

Entities:  

Mesh：

Year:  2005        PMID： 15729567     DOI： 10.1007/s00281-004-0195-x

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


  115 in total

Review 1.  Role of chemokines in the biology of natural killer cells.

Authors:  Michael J Robertson
Journal:  J Leukoc Biol       Date:  2002-02       Impact factor: 4.962

Review 2.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 3.  Ligands for natural killer cell receptors: redundancy or specificity.

Authors:  A Cerwenka; L L Lanier
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

4.  Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.

Authors:  J J Campbell; S Qin; D Unutmaz; D Soler; K E Murphy; M R Hodge; L Wu; E C Butcher
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 5.  Immune functions encoded by the natural killer gene complex.

Authors:  Wayne M Yokoyama; Beatrice F M Plougastel
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 6.  The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Authors:  Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

7.  Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.

Authors:  N C Fernandez; A Lozier; C Flament; P Ricciardi-Castagnoli; D Bellet; M Suter; M Perricaudet; T Tursz; E Maraskovsky; L Zitvogel
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

8.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

9.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Authors:  M J Smyth; E Cretney; K Takeda; R H Wiltrout; L M Sedger; N Kayagaki; H Yagita; K Okumura
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

10.  Gamma delta T cells provide an early source of interferon gamma in tumor immunity.

Authors:  Yunfei Gao; Wancai Yang; Meng Pan; Eileen Scully; Michael Girardi; Leonard H Augenlicht; Joe Craft; Zhinan Yin
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307
View more
  21 in total

1.  Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia.

Authors:  David Cervi; Yuval Shaked; Mehran Haeri; Tatiana Usenko; Christina R Lee; Jody J Haigh; Andras Nagy; Robert S Kerbel; Eitan Yefenof; Yaacov Ben-David
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

2.  FimH can directly activate human and murine natural killer cells via TLR4.

Authors:  M Firoz Mian; Nicole M Lauzon; David W Andrews; Brian D Lichty; Ali A Ashkar
Journal:  Mol Ther       Date:  2010-05-04       Impact factor: 11.454

Review 3.  Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity.

Authors:  A Fuchs; M Colonna
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23

4.  The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells.

Authors:  Amanda K Purdy; Diana A Alvarez Arias; Jennifer Oshinsky; Ashley M James; Ilya Serebriiskii; Kerry S Campbell
Journal:  J Immunol       Date:  2014-09-19       Impact factor: 5.422

5.  Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response.

Authors:  Rebekah K O'Donnell; Rosemarie Mick; Michael Feldman; Satoshi Hino; Yan Wang; Marcia S Brose; Ruth J Muschel
Journal:  Cancer Lett       Date:  2007-06-18       Impact factor: 8.679

6.  Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Authors:  Mostafa Jarahian; Carsten Watzl; Philippe Fournier; Annette Arnold; Dominik Djandji; Sarah Zahedi; Adelheid Cerwenka; Annette Paschen; Volker Schirrmacher; Frank Momburg
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

7.  Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients.

Authors:  Luca Degrate; Cinzia Nobili; Claudio Franciosi; Roberto Caprotti; Fernando Brivio; Fabrizio Romano; Biagio Eugenio Leone; Rosangela Trezzi; Franco Uggeri
Journal:  Langenbecks Arch Surg       Date:  2008-08-01       Impact factor: 3.445

8.  Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge.

Authors:  Amanda Kwant-Mitchell; Elishka A Pek; Kenneth L Rosenthal; Ali A Ashkar
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

9.  Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.

Authors:  Linda Witek-Janusek; Kevin Albuquerque; Karen Rambo Chroniak; Christopher Chroniak; Ramon Durazo-Arvizu; Herbert L Mathews
Journal:  Brain Behav Immun       Date:  2008-03-21       Impact factor: 7.217

10.  Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.

Authors:  Liat Binyamin; R Katherine Alpaugh; Tracey L Hughes; Charles T Lutz; Kerry S Campbell; Louis M Weiner
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.